0 results for 'Cardinal Health'
Plaintiffs Counsel Jayne Conroy: Trials Have Been 'Front and Center' in Driving Opioid Settlements
"The trial is the place where—win or lose—the information gets out to the public and people can start to look at it and even build on it for the next case that comes around," says Conroy, one of the three co-leads of the plaintiffs' executive committee in the National Prescription Opiate Litigation MDL.
CVS, Walgreens Pay $10B to Resolve Thousands of Opioid Lawsuits
The agreements in principle, announced on Wednesday, are dependent on the participation of cities, counties and states suing the pharmacies over the opioid crisis.
Pa. Among States Participating in $10 Billion Opioid Settlement With CVS, Walgreens
The agreements in principle, announced on Wednesday, are dependent on the participation of cities, counties and states suing the pharmacies over the opioid crisis.
$13.5 Million From Opioid Settlement Arrives in Connecticut
The funds will be distributed throughout Connecticut, with 15% set to go to cities, and 85% earmarked for the state.
Women of Legal Tech: 'Your First Table Isn't in the C-Suite, They're All Around,' Says Kailee Goold
Kailee Goold, VP, Litigation and Operations at Cardinal Health, discusses the impact Division 1 athletics had on her career success, how small moments accumulate to combat sexism in the workplace, and why being yourself is so important.
Law Journal Press | Digital Book
Health Care Benefits Law
Authors: Jeffrey D. Mamorsky
View this Book
View more book results for the query "Cardinal Health"
Taking Stock of the Shrinking, But Still Massive, Opioid Docket
A half-dozen years after the first cases seeking to hold drug companies, distributors and pharmacies liable for the costs of dealing with the opioid crisis, our colleague Amanda Bronstad gives a thorough rundown of the current state of play.
Lawyers Got Billions From Opioid Companies, But Legal Fight Far From Over
Drug companies settled opioid lawsuits for billions of dollars this year, and some filed for bankruptcy, but several closely watched appeals are coming up, and, for some defendants, such as pharmacies, the fight has just begun.
Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement
Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.
Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement
Teva negotiated the deal with the plaintiffs executive committee in the opioid multidistrict litigation, along with a "working group" of attorneys general of 12 states, including Texas, California, New York and Pennsylvania.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Andy Goldberg, Laner Muchin Managing Partner 1 minute read
- Legal Speak at Legalweek 2024: Priori CEO and Co-Founder Basha Rubin; Shook, Hardy & Bacon Partner Patrick Oot 1 minute read
Resources
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now